Showing results (111-120 of 161) with videos related to
Sort By:
Pageof 17
AIDS Research and Human Retroviruses|September 15, 2015
High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years Among HIV-Infected Persons in the Era of Modern Antiretroviral TherapyGerome V Escota, Kristin Mondy, Tim Bush, et al.Plos One|July 28, 2025
Potential impacts of 2.3.4.4b highly pathogenic H5N1 avian influenza virus infection on Snow Goose (Anser caerulescens) movement ecologyJeffery D Sullivan, Michael L Casazza, Rebecca L Poulson, et al.Vaccine|July 6, 2010
Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220E T Overton, M Kang, M G Peters, et al.The Patient|May 31, 2021
Patient-Reported Outcomes Through 1 Year of an HIV-1 Clinical Trial Evaluating Long-Acting Cabotegravir and Rilpivirine Administered Every 4 or 8 Weeks (ATLAS-2M)Vasiliki Chounta, Edgar T Overton, Anthony Mills, et al.The Journal of Infectious Diseases|July 10, 2020
Physical Function Impairment and Frailty in Middle-Aged People Living With Human Immunodeficiency Virus in the REPRIEVE Trial Ancillary Study PREPARETriin Umbleja, Todd T Brown, Edgar T Overton, et al.The Journal of Applied Ecology|February 16, 2016
Integrating spatially explicit indices of abundance and habitat quality: an applied example for greater sage-grouse managementPeter S Coates, Michael L Casazza, Mark A Ricca, et al.The Journal of Infectious Diseases|October 8, 2010
Factors associated with prevalent abnormal anal cytology in a large cohort of HIV-infected adults in the United StatesL Conley, T Bush, T M Darragh, et al.The Journal of Infectious Diseases|November 18, 2021
COVID-19 Vaccination Rates in a Global HIV CohortEvelynne S Fulda, Kathleen V Fitch, Edgar T Overton, et al.Sexually Transmitted Diseases|October 23, 2010
Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study)Erna Milunka Kojic, Susan Cu-Uvin, Lois Conley, et al.Journal of Clinical Pharmacology|June 25, 2021
Pharmacokinetics of Ruxolitinib in HIV Suppressed Individuals on Antiretroviral Agent Therapy from the ACTG A5336 StudySelwyn J Hurwitz, Sijia Tao, Christina Gavegnano, et al.Pageof 17